BioSpace News Archive

Genetown

Immunitas Therapeutics Presents Data for Novel Anti CLEC2D-TLR9 Conjugate Program at the Society for Immunotherapy of Cancer 2023 Annual Meeting

Immunitas Therapeutics (“Immunitas”) today announced it will present the first proof-of-concept data on its second program, a myeloid and B cell modulating anti CLEC2D-Toll-like receptor 9 (TLR9) agonist conjugate, at the Society for Immunotherapy of Cancer’s 38th Annual Meeting.

October 31, 2023
·
2 min read
Biotech Beach

ATEC Equipped to Support Ramping Surgical Volume With Proceeds From Secondary Offering

Alphatec Holdings, Inc. announced that the successful close of a $150 million secondary offering on October 27, 2023, positions the Company to accelerate investment in the revenue-generating assets required to capitalize on industry disruption.

October 31, 2023
·
5 min read
Deals

Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering

Avenue Therapeutics, Inc. today announced the pricing of its public offering of an aggregate of 16,633,400 units at a public offering price of $0.3006 per unit.

October 31, 2023
·
5 min read
Genetown

Affini-T Therapeutics to Present Preclinical Gene Editing Data from its Program Targeting KRAS G12D at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Affini-T Therapeutics to Present Preclinical Gene Editing Data from its Program Targeting KRAS G12D at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting.

October 31, 2023
·
2 min read
Genetown

Nimbus Therapeutics Presents Positive Preliminary Data from Clinical Trial of HPK1 Inhibitor in Solid Tumors at SITC Annual Meeting

Nimbus Therapeutics today announced initial data from the company’s ongoing Phase 1/2 study of NDI-101150, a small-molecule inhibitor of HPK1, which are being presented in a poster at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting in San Diego, CA.

October 31, 2023
·
3 min read
Exactech Announces First Surgeries Using Activit-E™ for Knee Replacement

Exactech announced the successful first surgery using its new, advanced Activit-E™ polyethylene for the Truliant® knee replacement system.

October 31, 2023
·
3 min read
MustGrow Receives USDA Organic Approval for Biological Fertilizer and Soil Amendment Technology

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”) is pleased to announce receipt of organic compliance certification from the USDA National Organic Program

October 31, 2023
·
10 min read
Awakn Life Sciences Engages Orphan Insight Ltd. to Advance Market Access, Pricing, and Reimbursement Strategies for AWKN-P001 Targeting Severe Alcohol Use Disorder

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a clinical-stage biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD)

October 31, 2023
·
7 min read
Genetown

Palleon to Present New Findings on Colorectal Tumor Microenvironment Identified with its HYDRA Platform at Society for Immunotherapy of Cancer (SITC) Annual Meeting

Palleon Pharmaceuticals today announced that it will present new findings from a study leveraging its HYDRA platform that suggests a link between stromal hypersialylation and immunosuppression activity within the colorectal tumor microenvironment at the Society for Immunotherapy of Cancer’s 38th Annual Meeting taking place in San Diego.

October 31, 2023
·
2 min read
Business

Fresenius Medical Care appoints Craig Cordola as new Management Board member for Care Delivery

Fresenius Medical Care has appointed Craig Cordola (52) as new Management Board member for the globally operating Care Delivery segment.

October 31, 2023
·
4 min read